Alfred Sze-Lok Cheng

6PUBLICATIONS

133CO-AUTHORS

Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersHaematological tumoursCell and nuclear divisionCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 03, 2026

EpiATLAS - a reference for human epigenomic research.

|Dec 13, 2025

Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential.

Clooney C Y Cheng, Ming Fung Cheung, Ah Young Lee

|Jul 14, 2025

FADD Activation in Hepatocellular Carcinoma Potentiates CD8+ T-cell Responses and Sensitizes to Immune Checkpoint Inhibitors.

Jiahuan Lu, Thomas Ting-Hei Chan, Yun Wang

|May 14, 2025

Tumor Suppressor Genes with Segmental Duplications Are Prone to Somatic Deletions and Structural Variations.

Ziheng Huang, Lin Zhang, Huarong Chen

|Apr 08, 2021

A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma.

Weiqin Yang, Yu Feng, Jingying Zhou

|Feb 21, 2019

New guidelines for DNA methylome studies regarding 5-hydroxymethylcytosine for understanding transcriptional regulation.

Le Li, Yuwei Gao, Qiong Wu

Pageof 1

Frequent Collaborators

Weiqin Yang

Kevin Y Yip

Ka-Fai To

Clooney Cheuk Yin Cheng

Ming Fung Cheung

Savio Ho-Chit Chow

Yalin Tu

Paul Bo-San Lai

Anthony Wing-Hung Chan

2 joint publications

Wei Kang

Frequent Collaborators

Weiqin Yang

Kevin Y Yip

Ka-Fai To

Clooney Cheuk Yin Cheng